Alicia Gomez is a dedicated Social Work Coordinator Consultant at BridgeBio Gene Therapy, with a passion for improving patient outcomes and enhancing the quality of care in the biotechnology industry. With a strong background in social work and healthcare, Alicia brings a unique perspective to drug safety and patient support programs. She is committed to developing innovative strategies that prioritize patient well-being and safety while ensuring compliance with regulatory standards.
Alicia's expertise lies in designing and implementing comprehensive patient support initiatives that address the holistic needs of individuals navigating complex treatment regimens. Her collaborative approach fosters partnerships with healthcare professionals, advocacy groups, and patients to create tailored solutions that optimize therapy adherence and minimize risks.
At the World Drug Safety Congress Americas 2025, Alicia will share her insights on leveraging technology and data-driven approaches to enhance performance and efficiency in drug safety practices. With a focus on innovation and continuous improvement, she aims to empower safety professionals and partners to embrace cutting-edge solutions that drive positive outcomes for patients and stakeholders.
Alicia's commitment to excellence, coupled with her compassionate approach to patient care, makes her a valuable asset in the field of drug safety and social work coordination. Her dedication to advancing safety standards and promoting collaboration across disciplines underscores her role as a thought leader in the biotechnology industry.